Premium
P1‐174: PRETREATMENT WITH DAPAGLIFLOZIN PROVIDES NEUROPROTECTIVE EFFECTS FOLLOWING CARDIAC ISCHEMIC/REPERFUSION (I/R) INJURY BY DECREASING AMYLOID BETA AGGREGATION AND BLOOD‐BRAIN BARRIER BREAKDOWN
Author(s) -
Sriwichaiin Sirawit,
Lahnwong Sarayut,
Apaijai Nattayaporn,
Chattipakorn Kenneth,
Kerdphoo Sasiwan,
Jaiwongkam Thidarat,
Chattipakorn Nipon,
Chattipakorn Siriporn C.
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.729
Subject(s) - neuroprotection , medicine , cardiac function curve , oxidative stress , brain damage , endocrinology , microglia , dapagliflozin , pharmacology , diabetes mellitus , inflammation , heart failure , type 2 diabetes